These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7016082)

  • 1. Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries.
    Szczeklik A; Gryglewski RJ
    Artery; 1980; 7(6):488-95. PubMed ID: 7016082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipoproteins, lipid peroxides and prostacyclin biosynthesis in patients with coronary heart disease.
    Szczeklik A; Gryglewski RJ; Domagała B; Zmuda A; Hartwich J; Woźny E; Grzywacz M; Madej J; Gryglewska T
    Prostaglandins; 1981 Nov; 22(5):795-807. PubMed ID: 7036228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of hyperlipidemic sera and lipoproteins on prostacyclin synthesis by rabbit aortic smooth muscle cells].
    Hu YH; Wang Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):366-71. PubMed ID: 2534618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein fractions in idiopathic hyperlipoproteinaemia.
    Kłosiewicz-Latoszek L; Naruszewicz M; Cybulska B; Szostak WB; Chotkowska E
    Acta Physiol Pol; 1982; 33(1-2):47-56. PubMed ID: 7158380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability.
    Szczeklik A; Gryglewski RJ; Domagala B; Dworski R; Basista M
    Thromb Haemost; 1985 Aug; 54(2):425-30. PubMed ID: 3909500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lipoproteins from pre-eclamptic women on umbilical endothelial cell 6-oxo-prostaglandin f1alpha and endothelin 1 synthesis, and nitric oxide synthase 3 mRNA expression.
    Barden A; Beilin LJ; Both K; Ritchie J; Leedman P; Walters BN; Michael CA
    Clin Sci (Lond); 1999 Dec; 97(6):697-706. PubMed ID: 10585897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prostaglandin I2 (PGI2) formation by LDL-cholesterol or LDL-peroxides?
    Beitz J; Panse M; Fischer S; Hora C; Förster W
    Prostaglandins; 1983 Dec; 26(6):885-92. PubMed ID: 6396733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prostacyclin formation by lipid peroxides in the arterial wall: hypothetical step in development of atherosclerosis.
    Gryglewski RJ; Szczeklik A
    Mater Med Pol; 1978; 10(4):338-41. PubMed ID: 113631
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins.
    Fleisher LN; Tall AR; Witte LD; Miller RW; Cannon PJ
    J Biol Chem; 1982 Jun; 257(12):6653-5. PubMed ID: 7045092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High density lipoprotein can modulate the inhibitory effect of oxLDL on prostacyclin generation by rat aorta in vitro.
    Mahfouz MM; Kummerow FA
    Prostaglandins Other Lipid Mediat; 2003 Nov; 72(3-4):91-114. PubMed ID: 14674623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized lipoproteins in blood plasma: possible marker of atherosclerosis progression.
    Moriel P; Okawabata FS; Abdalla DS
    IUBMB Life; 1999 Oct; 48(4):413-7. PubMed ID: 10632571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of human plasma lipoproteins on ionic conductivity of lipid bilayer membranes].
    Martseniuk OV; Perova NV; Gerasimova EN; Tverdislov VA; El-Karadagi S
    Vopr Med Khim; 1980; 26(4):484-9. PubMed ID: 7456387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the composition of the lipoproteins in human lymph].
    Kostner G
    Hoppe Seylers Z Physiol Chem; 1972 Dec; 353(12):1863-71. PubMed ID: 4346529
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K; Kiessling H
    Artery; 1981; 9(6):456-76. PubMed ID: 7337554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of vascular prostacyclin generation by jaundiced serum: relation to lipid peroxides.
    Schroeder ET; Finn AF; Hueber P
    J Lab Clin Med; 1988 Dec; 112(6):784-91. PubMed ID: 3057094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High density lipoprotein-induced cardiac prostacyclin synthesis in vitro: relationship to cardiac arachidonate mobilization.
    Van Sickle WA; Wilcox HG; Malik KU; Nasjletti A
    J Lipid Res; 1986 May; 27(5):517-22. PubMed ID: 3090180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function and structure of plasma lipoproteins.
    Fredrickson DS
    Horm Metab Res; 1974; Suppl 4():2-6. PubMed ID: 4371654
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostacyclin production and lipid peroxidation in the aorta of rats fed with cholesterol autoxidation products.
    Martinez-Sales V; Fornas E; Camañas A
    Artery; 1985; 12(4):213-9. PubMed ID: 3935095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of PGI2 synthetase within the arterial wall by 15-hydroperoxyarachidonic acid enhances local white platelet thrombosis.
    Bourgain RH
    Haemostasis; 1980; 9(6):345-51. PubMed ID: 6778799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.